Richard Rodgers
Director/Board Member at ARDELYX, INC.
Net worth: 2 M $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
David Mott | M | 58 | 15 years | |
George Kemble | M | 63 | 13 years | |
John Trizzino | M | 64 | 10 years | |
Elizabeth Grammer | F | 60 | 12 years | |
James Young | M | 71 | 14 years | |
Merdad Parsey | M | 61 | 14 years | |
Justin Renz | M | 52 | 4 years | |
Cam Gallagher | M | 54 | 5 years | |
David Happel | M | 62 | 2 years | |
Mike Raab Raab | M | 59 | 15 years | |
Amy Rabourn | F | 44 | 5 years | |
Beth Seidenberg | M | 67 | 17 years | |
John Jacobs | M | 57 | 1 years | |
Bernhard Hoffmann | M | 68 | 6 years | |
Robert Felsch | M | - | 4 years | |
Laura Williams | M | 61 | 4 years | |
Muna Bhanji | F | 61 | 3 years | |
George Magrath | M | 40 | 1 years | |
Erik Sims | M | - | 3 years | |
Brian Rosen | M | - | 9 years | |
Jay Pepose | M | 69 | 3 years | |
Sean Ainsworth | M | 56 | 6 years | |
Robert Bazemore | M | 56 | 8 years | |
Caitlin Lowie | F | - | 2 years | |
Onaiza Cadoret-Manier | F | 60 | 4 years | |
James Kelly | M | 58 | 3 years | |
Elizabeth Rozek | F | 53 | 1 years | |
Silvia Taylor | F | - | 4 years | |
Margaret McGlynn | F | 64 | 4 years | |
James Armitage | M | 77 |
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | 14 years |
Gale Smith | M | - | 20 years | |
William Bertrand | M | 59 | 9 years | |
Gregg Alton | M | 58 | 4 years | |
Susan Benton | F | 59 | 4 years | |
Richard Douglas | M | 71 | 14 years | |
Jan Lundberg | M | 70 | 6 years | |
Mark Joseph Casey | M | 60 | 1 years | |
Rachel King | F | 64 | 6 years | |
James Manuso | M | 75 | 5 years | |
Nirav Jhaveri | M | 46 | - | |
Troy Morgan | M | - | 3 years | |
Denny Kim | M | - | 3 years | |
Raburn Mallory | M | - | 4 years | |
Johann Bono | M | - | - | |
Ursula Matulonis | F | - | - | |
Duncan Jodrell | M | - | - | |
Seth Toback | M | - | 4 years | |
Barbara Withers | F | - | - | |
Erika Schultz | F | - | - | |
Ronil Patel | M | - | 3 years | |
Robert Blanks | M | 64 | 11 years | |
Frank D. Czworka | M | 55 | 4 years | |
Henrietta Ukwu | M | 64 | 3 years | |
Drey Coleman | F | - | - | |
Arnold Lewis Oronsky | M | 83 | 13 years | |
Timothy Jon Hahn | M | 60 | 4 years | |
Filip Dubovsky | M | 59 | 4 years | |
Biegie Lee | M | - | 7 years | |
Chris Dunne | M | - | 14 years | |
David Rosenbaum | M | 63 | 14 years | |
Gaeton Biscardi | M | - | - | |
Mitchell Brigell | M | - | - | |
Jinzi Wu | M | 61 | 5 years | |
Joseph Schachle | M | 59 | 1 years | |
Iksung Cho | M | - | 9 years | |
Anne-Marie O'Farrell | M | - | 11 years | |
Alison Chartan | F | - | 3 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Mary Lynne Hedley | M | 61 |
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA.
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | 16 years |
Lonnie Moulder | M | 66 |
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | 10 years |
Douglas Swirsky | M | 54 | 2 years | |
Chang Ho Ahn | M | 72 | 16 years | |
Mina Sooch | F | 56 | 5 years | |
Mark E. Kaufmann | M | 56 | 9 years | |
Stanley Erck | M | 76 | 14 years | |
Gordon Ringold | M | 73 | 14 years | |
Joseph Oriti | M | 44 | - | |
John Herrmann | M | 58 | 13 years | |
Anthony Rimac | M | 60 | 1 years | |
Patrick Soon-Shiong | M | 71 |
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | 3 years |
Dominique Charmot | M | 69 | 7 years | |
Tae Heum Jeong | M | 53 | 15 years | |
Richard R. Roscitt | M | 72 | 2 years | |
Edward C. English | M | 57 | 5 years | |
Peter G. Schultz | M | 67 | 8 years | |
Jennifer Davis Ruff | F | - | 5 years | |
Jill Hoyt | F | - | 15 years | |
Rakesh Soni | M | 68 | 7 years | |
Si Moon Hwang | M | 55 | 3 years | |
Keith Santorelli | M | - | - | |
Annalisa Jenkins | M | 58 | 5 years | |
Geoffrey A. Block | M | 58 | 4 years | |
Eric P. Loukas | M | 67 |
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | 7 years |
Jeffrey W. Jacobs | M | 61 | 13 years | |
Paul Walker | M | 49 | 4 years | |
Jean M. Fréchet | M | - | 7 years | |
William Cadogan | M | 75 | 14 years | |
David Collier | M | 61 | - | |
Peter David Suzdak | M | 65 | 5 years | |
Russell Wilson | M | 64 | 12 years | |
David F. Fisher | M | 75 | 5 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Richard Rodgers
- Personal Network